Peer Review History

Original SubmissionMarch 3, 2020
Decision Letter - Gregory S. Barsh, Editor, Bing Ye, Editor

Dear Kazuo,

Thank you very much for submitting your Research Article entitled 'Drosophila miR-87 promotes dendrite regeneration by targeting the transcriptional repressor Tramtrack69' to PLOS Genetics. Your manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important problem, but raised some substantial concerns about the current manuscript. Based on the reviews, we will not be able to accept this version of the manuscript, but we would be willing to review again a much-revised version. We cannot, of course, promise publication at that time.

Should you decide to revise the manuscript for further consideration here, your revisions should address the specific points made by each reviewer. Particularly, Reviewer 3 commented that additional evidence is needed to support the conclusion that developmental and injury-induced regeneration share a common intrinsic mechanism, all reviewers asked you to clarify the roles of nf4 and br in the process, and Reviewer 1 suggested additional experiments on the GFP sensor. The reviewers also noted that some control experiments are missing. We will also require a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

If you decide to revise the manuscript for further consideration at PLOS Genetics, please aim to resubmit within the next 60 days, unless it will take extra time to address the concerns of the reviewers, in which case we would appreciate an expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments are included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see our guidelines.

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool.  PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, use the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

[LINK]

We are sorry that we cannot be more positive about your manuscript at this stage. Please do not hesitate to contact us if you have any concerns or questions.

Yours sincerely,

Bing Ye

Guest Editor

PLOS Genetics

Gregory Barsh

Editor-in-Chief

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: Summary: Kitatani, et al. present an interesting study showing that the microRNA, miR-87, is required for adult-specific dendritic growth during pupal metamorphosis. Loss of miR-87 impairs dendrite regeneration whereas over-expression of miR-87 leads to early initiation of regeneration. Moreover, miR-87 acts in a cell-autonomous manner to regulate dendritic growth. The authors present evidence consistent with Tramtrack 69 (ttk69) being a functional target of miR-87 and reducing ttk69 expression in miR-87 KO neurons restores dendritic growth. Finally, the authors show that miR-87 is required for dendrite regeneration after acute injury.

Major comments

1.) Throughout the manuscript and figures the exact genotype of “wild-type” is not clear. This leads to uncertainty about whether proper controls were used for each experiment. Presumably the wild-type in Figures 1, 3 and 4 is a fly with the same genetic background as the miR-87 KO mutant. For Figures 5, 6, and 7 it is not clear if the wild-type control is a GAL4-only control, a UAS-only control, or some other type of genetic background control. Making the genotype for each control explicitly clear is essential.

2.) Figure 4 - The authors should examine fluorescence from the control GFP sensor in miR-87 KO flies during 2L and WP stages to see if there are uniform levels of GFP expression in C4da neurons. Further, the methods used by the authors to quantify fluorescence in Figure 4H are unclear. The authors should quantify fluorescence of the miR-87 GFP sensor in WT and miR-87 KO neurons and normalize the data to fluorescence intensity of the control GFP sensor lacking miR-87 binding sites. This would demonstrate additional confidence that control of the miR-87 GFP sensor is dependent on miR-87 activity.

3.) Figure 6 - The authors indicate that over-expression of three miR-87 targets, ttk69, hnf4, and br, caused significant defects in dendrite regeneration. They follow up with dosage-sensitive interactions between the candidate genes and miR-87. However, only data for ttk69 is provided. Similar data for hnf and br should be shown. Specifically, assaying whether heterozygous loss-of-function mutations in hnf and br could suppress the regeneration defect in miR-87 KO neurons. If all three candidate genes show similar levels of suppression, the manuscript should specifically address why ttk69 was chosen for follow-up experiments. If the loss-of-function studies were inconclusive, those data should be included.

4) The supplemental videos are helpful, but I was struck by how the dendrites in the mutants appeared to fasciculate more than the wild-type. Given that these dendrites typically exhibit self-avoidance, in order to tile in the animal, could the authors comment on whether that is an observation that was made in the other live imaging studies? Is there a way to measure number of contacts observed? I do not need the authors to add additional data, commenting on this possibility would be sufficient, but if they have that data tabulated, adding it would be good.

5) The authors provide compelling evidence that ttk69 interacts genetically, and evidence that levels of ttk69 are elevated in miR-87 mutants. A complete proof that miR-87 regulates ttk69 post-transcriptionally would likely necessitate manipulating the 3’UTR binding sites in ttk69 and rescuing that by mutating miR-87 to recover binding and regulation. Thus, I would ask the authors to simply mention in the discussion that their evidence is consistent with the 3’ UTR regulation, but that there are potentially other factors that miR-87 could be regulating upstream of ttk69.

Minor comments

1.) Figure 1- Ideally, the authors should show representative images for dendrites at 48-hr APF and in 2-day and 3-day-old adults. Perhaps it would be easier to break this figure up into two figures, one for dendritic growth after puparium formation and a second figure for dendritic growth post-eclosion.

2.) p.8, 2nd paragraph - AFP should be APF

3.) p.10, 1st paragraph. Figure call-out error “…by the miR-87 sensor beginning in 3rd instar larvae, resulting in a >50% reduction of GFP expression in early pupal stages (Fig 4B-4G). However, 4B and 4C have control sensor data.

4.) p.15, 2nd paragraph - “…suggesting that the increased expression of miR-87…”. Expression of miR-87 was never demonstrated, only increased activity through the GFP sensor.

5.) In Figures 5, 6, and 7 the genotypes of each fly line are not clear. It would be helpful to write out the genotypes in the figure legend similar to the genotypes of MARCM clones in Figure 2.

“Clone genotypes: (WT) hsFLP, ppk-Gal4, UASmCD8GFP/+; FRT40A, (miR-87) hsFLP, ppk-Gal4, UAS-mCD8GFP/+; miR-87, FRT40A, and (miR-87 + UAS-miR-87) hsFLP, ppk-Gal4, UAS-mCD8GFP/+; miR-87, FRT40A; UAS-miR-87/+.”

5.) A section in the Methods should be added for quantification of GFP fluorescence in Figures 4 and 7.

6.) The authors quantify dendritic field size in Figure 2, but not in any other experiments. I did not see a rationale for this.

7.) p.30, Figure 3 legend - “Time stumps” should be “Time stamps”

8.) Could the authors please comment on when the pickpocket enhancer becomes active in the C4da neurons?

9.) Could the authors please confirm that the total dendritic length is the sum of all the dendrites from a single neuron. Or is it from multiple neurons within the same animal?

Reviewer #2: This study has demonstrated that microRNA miR-87 contributes to neuronal dendrite outgrowth in both developmental and injury-induced regeneration and has shown its underlying molecular mechanism at least at the level of identifying a critical target of miR-87, ttk69. All of the experiments were done in scientifically sound manners and the data are appropriately presented.

Minor comments:

1. What is the role of the miR-87 target, ttk69, in dendrite morphogenesis and regeneration of C4da neurons? The authors state roles of ttk69 in C1da neurons and R7 photoreceptor. If the role of ttk69 in C4da neurons is not known, state as such.

2. The positive hits of the primary screening of the miR-67 targets were hnf4, br and ttk69 (Figure 6A and 6B) and the authors examined ttk69 in their secondary test (Figure 6C and 6D). What happened to hnf4 and br? If they were negative in the secondary test or if the authors did not examine those candidates further, state as such.

3. It is preferable to describe the clone genotype in Figure 5 legend (did I overlook at it?)

Reviewer #3: Drosophila miR-87 promotes dendrite regeneration by targeting the transcriptional repressor Tramtrack69 (PGENETICS-D-20-00327)

In this manuscript the authors provide genetic evidence to report that microRNA miR-87 is required not only for the developmentally programed dendrite regeneration of Drosophila sensory neurons during metamorphosis, but also for the injury-induced dendrite regeneration of larval neurons. By monitoring the miR-87 sensor, they further show that the activity of miR-87 is upregulated in neurons during larvae-to-pupae transition, prior to dendrite regeneration, and also in larval neurons after dendrite injury. Finally, they identify one of the miR-87 targets, ttk69, and show that miR-87-mediated reduction of ttk69 is required to promote both the developmentally programed and the injury-induced dendrite regeneration.

The genetic studies of this manuscript are well designed and carried out. The miR-87 activity reported by the miR-87 sensor is nicely shown correlated with the ability of dendrite regeneration in C4da neurons, and with the reduction of ttk69 expression in neurons. The manuscript would need some improvement for it to be accepted by the journal. Here are the two main issues that I would like to raise for this manuscript.

First, the authors have done a lot for the developmentally programed dendrite regeneration; however, less has been done for the injury-induced dendrite regeneration of larval neurons. To support their main conclusion that a common intrinsic mechanism, ttk69 downregulation by miR-87 to promote dendrite growth in C4da neurons, is shared by both cases, the authors need to provide more evidence for the dendrite regeneration in larval neurons after injury.

1) In Fig 5, the authors show that miR-87 overexpression could cause precocious dendrite growth in C4da neurons at 30 hr APF. Does miR-87 overexpression also cause precocious dendrite growth in larval C4da neurons after injury?

2) In Fig 6, the authors show that ttk69 overexpression causes dendrite regeneration defects in C4da neurons at 72 hr APF. Does ttk69 overexpression also cause impaired dendrite growth in adult C4da neurons, like the ones in miR-87 KO adults (Fig 1)? Does ttk69 overexpression also cause impaired dendrite growth in larval C4da neurons after injury?

Second, the current results provided in this manuscript only suggest that ttk69 is likely one of the miR-87 target genes for dendrite regeneration. Although the authors show in Fig 6 that no decrease of ttk69 mRNA in the brain extracts of miR-87 KO animals at white pupal stages, this result still indirectly suggest that ttk69 is one miR-87 target in the brain. If the authors could provide evidence to demonstrate that ttk69 is the real target of miR-87 in C4da neurons, it would greatly strengthen the mechanistic insights into this manuscript.

Other points:

1) Do the authors try to rescue dendrite regeneration defects in miR-87 KO neurons with removal of one copy of hnf4 or br, or with RNAi of either genes? Or any combination of these three candidate genes reduction to see whether it can improve the rescue efficiency of dendrite regeneration defects in miR-87 KO neurons by single gene reduction?

2) On page 9, the cited information in the sentence, “A previous northern blot analysis has shown that miR-87 expression in the brain ……”, is not quite correct, according to ref 40. They used RNA from the whole animals, not the brain, at various developmental stages for northern blot analysis.

3) In the Discussion, the authors discuss the possible mechanism of temporal regulation of miR-87 expression dynamics, and think ecdysone might control the temporal expression of miR-87. However, according to the information in ref 40, the experimental manipulation of ecdysone or Juvenile hormone signaling in S2 cells (done by the authors of ref 40) does not affect the expression of miR-87. I think the authors should include this information and discuss other possibility that could regulate miR-87 expression temporally.

4) The results shown in Fig 2 demonstrated that dendrite regeneration defects were largely, not fully, rescued by UAS-miR-87 expression in the miR-87 MARCM clones of C4da neurons, suggesting that mir-87 has a role acting cell-autonomously in neurons for dendrite regeneration. Since it is not fully rescued by UAS-miR-87 expression in miR-87 MARCM clones, compared to the wild-type clones, it may suggest a possibility that miR-87 might also have a cell-non-autonomous role in dendrite regeneration. Have the authors done any experiments to rule out this possibility? Or can the authors discuss it in the Discussion?

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Revision 1

Attachments
Attachment
Submitted filename: 2020 Kitatani PLoS Genetics Rebuttal final submitted.docx
Decision Letter - Gregory S. Barsh, Editor, Bing Ye, Editor

Dear Dr Emoto,

We are pleased to inform you that your manuscript entitled "Drosophila miR-87 promotes dendrite regeneration by targeting the transcriptional repressor Tramtrack69" has been editorially accepted for publication in PLOS Genetics. Congratulations!

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional accept, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org.

In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about one way to make your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Bing Ye

Guest Editor

PLOS Genetics

Gregory Barsh

Editor-in-Chief

PLOS Genetics

www.plosgenetics.org

Twitter: @PLOSGenetics

----------------------------------------------------

Comments from the reviewers (if applicable):

Reviewer 1 had several minor comments on writing styles and typos, which we would like the authors to address.

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: The authors have satisfactorily addressed the major comments from the first review.

Minor comments

1.) Line 201 - Figure callout should be Fig 4H.

2.) Line 216 - Figure callout should be Supplemental Fig S2

2.) Line 779 - Supplemental Figure S3 title does not match Figure S3 content

3.) Line 788 - ttk69+/- should read ttk69/+

4.) Line 807 - URT should read UTR

Reviewer #3: The revised version seems to be improved over the original paper. The authors have fully addressed my concerns. Therefore, I support its publication.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #3: No

----------------------------------------------------

Data Deposition

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository. As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website.

The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: 

http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-20-00327R1

More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support.

Additionally, please be aware that our data availability policy requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

----------------------------------------------------

Press Queries

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org.

Formally Accepted
Acceptance Letter - Gregory S. Barsh, Editor, Bing Ye, Editor

PGENETICS-D-20-00327R1

Drosophila miR-87 promotes dendrite regeneration by targeting the transcriptional repressor Tramtrack69

Dear Dr Emoto,

We are pleased to inform you that your manuscript entitled "Drosophila miR-87 promotes dendrite regeneration by targeting the transcriptional repressor Tramtrack69" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Matt Lyles

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom

plosgenetics@plos.org | +44 (0) 1223-442823

plosgenetics.org | Twitter: @PLOSGenetics

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .